Algo version: 0.98b
Qingdao NovelBeam is listed at the SHH Exchange
Qingdao NovelBeam [688677.SS]
SHH Sector: Healthcare Industry:Medical - Instruments & Supplies

Is Qingdao NovelBeam stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Qingdao NovelBeam pays dividends. Last time was Tuesday 11th of June 2024 where the investors holding the stock on Tuesday 11th of June 2024 were paid CNY0.55 per share. Over the last 4 times between 2021 and 2024, Qingdao NovelBeam has paid CNY2.48 with an average of CNY0.62 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Qingdao NovelBeam 10 years ago, but if you had invested on Friday 26th of February 2021 when the price was CNY40.16, you would have made a loss of CNY-12.76 per share or -31.77%

Yes, the average daily trading liquidity for Qingdao NovelBeam is CNY887 403 thousand. You should therefore be able to get in and out of your positions relatively fast.

Qingdao NovelBeam has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 35.89, the company's ability to pay off the debt is good. Qingdao NovelBeam has a very good net profit margin of 30.92% and should have very high tolerances against inflation.

We have calculated the inflation risk for Qingdao NovelBeam to be low [0 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.